Invention Grant
- Patent Title: Extended release formulation of nevirapine
- Patent Title (中): 奈韦拉平的延长释放制剂
-
Application No.: US12523226Application Date: 2008-06-04
-
Publication No.: US08460704B2Publication Date: 2013-06-11
- Inventor: Michael L. Cappola , Svetlana Sienkiewicz , Glenn Charles Snow , Feng-Jing Chen
- Applicant: Michael L. Cappola , Svetlana Sienkiewicz , Glenn Charles Snow , Feng-Jing Chen
- Applicant Address: DE Ingelheim am Rhein
- Assignee: Boehringer Ingelheim International GmbH
- Current Assignee: Boehringer Ingelheim International GmbH
- Current Assignee Address: DE Ingelheim am Rhein
- Agent Michael P. Morris; Alan R. Stempel
- International Application: PCT/US2008/065705 WO 20080604
- International Announcement: WO2008/154234 WO 20081218
- Main IPC: A61K9/22
- IPC: A61K9/22 ; A61K9/00 ; A61K9/14 ; A61K9/28 ; A61K31/00 ; C07D223/10 ; C07D243/10 ; A01N43/00
Abstract:
The invention relates to an extended release pharmaceutical composition comprising nevirapine.
Public/Granted literature
- US20100278918A1 EXTENDED RELEASE FORMULATION OF NEVIRAPINE Public/Granted day:2010-11-04
Information query
